chitosan has been researched along with Atrophic Vaginitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, TC; Chen, ZY; Chou, YC; Kuan, CY; Lin, FH; Lin, IE; Lin, JN; Yang, IH | 1 |
| Bonferoni, MC; Ferrari, F; Puccio, A; Rossi, S; Sandri, G; Vigani, B | 1 |
2 other study(ies) available for chitosan and Atrophic Vaginitis
| Article | Year |
|---|---|
Synthesis, characterization, and evaluation of BDDE crosslinked chitosan-TGA hydrogel encapsulated with genistein for vaginal atrophy.
Topics: Animals; Atrophic Vaginitis; Caco-2 Cells; Cell Adhesion; Cell Survival; Chitosan; Drug Carriers; Female; Genistein; Humans; Hydrogels; Mice; Rats; Rats, Sprague-Dawley; Thioglycolates; Vagina | 2021 |
Chitosan Ascorbate Nanoparticles for the Vaginal Delivery of Antibiotic Drugs in Atrophic Vaginitis.
Topics: Amoxicillin; Anti-Bacterial Agents; Antioxidants; Aquatic Organisms; Ascorbic Acid; Atrophic Vaginitis; Cells, Cultured; Chitosan; Drug Compounding; Drug Delivery Systems; Drug Liberation; Excipients; Female; Fibroblasts; Freeze Drying; Humans; Nanoparticles; Oceans and Seas; Solubility; Wound Healing | 2017 |